5. Actos - Top 10 Warnings and Recalls
Drug: Actos
2006 sales: $3.05 billion
Manufacturer: Takeda
Safety concern: “black box;†heart failure
Related Articles:
> Takeda touts Actos as heart attack-free. Report
> Actos on a good-news roll. Report
> Actos study points to reduction in heart attacks, strokes. Report
> Diabetes drug helps reduce rate of strokes. Report
> Avandia, Actos don't boost death risk. Report
More stories about Actos
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: